Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Lennon
LENNON CODEINE PHOSPHATE TABLETS 30 mg SCHEDULING STATUS: S6 PROPRIETARY NAME (and dosage form): LENNON CODEINE PHOSPHATE TABLETS 30 mg COMPOSITION: Tablets containing 30 mg Codeine Phosphate . PHARMACOLOGICAL CLASSIFICATION: A 2.7 Narcotic Analgesics. PHARMACOLOGICAL ACTION: Codeine phosphate is a powerful analgesic which is effective due to its action on the central nervous system. It resembles morphine in its pharmacodynamic actions although much weaker in its effects. It has little sedative effects. INDICATIONS: For the relief of moderate pain. CONTRA-INDICATIONS: Codeine Phosphate is contra-indicated in respiratory depression, especially in the presence of cyanosis and excessive bronchial secretion, as well as acute alcoholism and head injuries, and conditions in which intracranial pressure is raised. It should not be given during an attack of bronchial asthma or in heart failure secondary to chronic lung disease. The administration of codeine phosphate is contra-indicated in patients taking monoamine oxidase inhibitors or within 10 days of stopping such treatment. WARNINGS: Exceeding prescribed dose, together with prolonged and continuous use of this medication, may lead to dependency and addiction. KEEP OUT OF REACH OF CHILDREN DOSAGE AND DIRECTIONS FOR USE: 15 mg to 60 mg daily. SIDE-EFFECTS AND SPECIAL PRECAUTIONS: Codeine phosphate may cause nausea, vomiting, constipation, drowsiness, confusion, dry mouth, sweating, facial flushing, vertigo, bradycardia, palpitations, orthostatic hypotension, hypothermia, restlessness, changes of mood and miosis. Micturition may be difficult, and there may be ureteric or biliary spasm; there is also an antidiuretic effect. Raised intracranial pressure may occur. Reactions such as urticaria and pruritis may occur. Contact dermatitis has been reported. Read the complete document